Citation

Verbeek DE, van Riezen J, de Boer RA, van Melle JP, de Jonge P. Heart Fail. Clin. 2011; 7(1): 89-99.

Affiliation

Department of Internal Medicine, Ziekenhuisgroep Twente, PO Box 7600, 7600 SZ Almelo, The Netherlands.

Copyright

(Copyright © 2011, Elsevier Publishing)

DOI

10.1016/j.hfc.2010.08.006

PMID

21109212

Abstract

Several kinds of systematic studies have been conducted verifying the putative association between β-blockers and depressive symptoms. However, many of these studies had important limitations in their design. In most of the studies, no effect of β-blockers on depressive symptoms was seen. Because individual susceptibility cannot be ruled out, clinicians must stay vigilant, especially with patients who have a positive personal or family history and who have been prescribed lipophilic β-blockers. However, fear for depression should not be the reason for reluctance in prescribing β-blockers to cardiovascular patients.

Language: en